The US advised its citizens to avoid trips to Mexico. Know why?

Due to the pandemic generated by COVID-19, the US advised its citizens to avoid trips to Mexico, Brazil, Ecuador, Paraguay and Peru

© Provided by Puros Viajes

The United States government this week placed Mexico, Brazil and other countries and territories in category 4 of coronavirus transmission, defined as “very high” risk, before advising its citizens not to travel to those countries.

In addition to Mexico, Chile, and Brazil, the Centers for Disease Control (CDC) also included Ecuador, Paraguay, Peru, the Philippines, Saint Vincent and the Grenadines, Singapore, Moldova, Kosovo, Anguilla and French Guiana.

In the case of Mexico, the North American country had been in the “high” risk level 3 category for six months, but the advance of the virus in recent weeks has led it to rise in category.

Level 4 implies a “do not travel” notice to the country in question and, if it is imperative to carry out that trip, the CDC recommends being fully vaccinated and warns that there is still a risk of contracting COVID-19.

Of the countries in the region, Colombia, Argentina, Bolivia, Venezuela, Uruguay, the Dominican Republic, Costa Rica and Panama already figured in that category.

In the case of Chile, the level 3 alert has been in force since Monday, which urges “reconsider the trip”, not only due to the complicated epidemiological situation, but also due to “civil tensions”.

This same Monday, the United States Food and Drug Administration (FDA) fully approved Moderna’s anticovid vaccine, which until now had authorization for emergency use.

In a statement, the US regulator explained that after this measure the vaccine will be marketed under the name Spikevax “to prevent COVID-19 in individuals 18 years of age and older.”

Moderna’s serum was approved for emergency use in the US for the elderly on December 18, 2020, and is the second COVID-19 vaccine to gain full FDA approval after Pfizer’s.

Outgoing FDA Commissioner Janet Woodcock noted that full approval “may instill greater confidence in making the decision to get vaccinated” among the population.

According to CDC data, more than 211 million people (63.8% of the population) have received the full course of the vaccine, while 87.8 million (41.5%) have received the booster dose.

Source: Infobae